Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Arena Pharmaceuticals, Inc. (ARNA)

« Back to company index

ARNA Chatter Timeline

Stock Ticker for ARNA

Most Active Tweeters for ARNA

UserTweets
@Tickeron 12
@Gambiste1 8
@AmericanBanking 8
@dispatchtribune 5
@OlympiaReport 5

Recent Tweets for ARNA

dakotafinancial @dakotafinancial
Arena Pharmaceuticals, Inc. $ARNA Given Consensus Rating of “Hold” by Brokerages https://t.co/6yZm4UjIbw
November 19th 2019, 11:11pm
TheMarketsDaily @TheMarketsDaily
Arena Pharmaceuticals, Inc. $ARNA Receives Average Recommendation of “Hold” from Analysts https://t.co/HAebqRH9XC
November 19th 2019, 11:11pm
tradersreport @tradersreport
RT @Tickeron: $ARNA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/9oNrznRG8X #ArenaP…
November 19th 2019, 3:11pm
Tickeron @Tickeron
$ARNA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/OD3pTzdxMa
November 19th 2019, 3:11pm
ConsumerFeed @ConsumerFeed
Arena Pharmaceuticals’ $ARNA Sell Rating Reaffirmed at Wood & Company https://t.co/LdFrCjqjm2
November 18th 2019, 11:11pm
bbnsnews @bbnsnews
Arena Pharmaceuticals’ $ARNA Sell Rating Reaffirmed at Wood & Company https://t.co/jBBc6aBXcP
November 18th 2019, 11:11pm
dakotafinancial @dakotafinancial
Arena Pharmaceuticals $ARNA Earns “Sell” Rating from Wood & Company https://t.co/FGH0au9Eut
November 18th 2019, 11:11pm
WatchlistN @WatchlistN
Arena Pharmaceuticals $ARNA Receives Sell Rating from Wood & Company https://t.co/7FqFoA6Fl8
November 18th 2019, 11:11pm
TickerReport @TickerReport
Arena Pharmaceuticals $ARNA Earns “Sell” Rating from Wood & Company https://t.co/UKN7Y6pl5f
November 18th 2019, 10:11pm
otcdynamics @otcdynamics
$ARNA California Life Sciences Association Honors Arena Pharmaceuticals at the Pantheon 2019 DiNA™ Awards for the D https://t.co/Y4JVn7aECW
November 18th 2019, 4:11pm
Gambiste1 @Gambiste1
RT @SharonAConklin: $ARNA https://t.co/67DeCqx3mb
November 18th 2019, 2:11pm
Tickeron @Tickeron
$ARNA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/iRjh8B26kV
November 18th 2019, 2:11pm
SharonAConklin @SharonAConklin
$ARNA https://t.co/67DeCqx3mb
November 18th 2019, 1:11pm
CrisprGuy @CrisprGuy
@MaxJacobsEdison @AdamSinger Ask $ARNA that. They’ve engineered a completely synthetic marijuana based drug. Even t… https://t.co/TijCP0BCko
November 18th 2019, 12:11pm
ZolmaxNews @ZolmaxNews
Bank of America Begins Coverage on Arena Pharmaceuticals $ARNA https://t.co/gkk40lafOP
November 17th 2019, 10:11pm
ConsumerFeed @ConsumerFeed
Arena Pharmaceuticals $ARNA Rating Lowered to Sell at BidaskClub https://t.co/WYM2VpbUYn
November 17th 2019, 9:11pm
OlympiaReport @OlympiaReport
BidaskClub Lowers Arena Pharmaceuticals $ARNA to Sell https://t.co/5UESr4cXH9
November 17th 2019, 8:11pm
dispatchtribune @dispatchtribune
Arena Pharmaceuticals $ARNA Lowered to “Sell” at BidaskClub https://t.co/XuI2REMhQI
November 17th 2019, 8:11pm
bbnsnews @bbnsnews
Brokerages Set Arena Pharmaceuticals, Inc. $ARNA Target Price at $63.33 https://t.co/xLJhbIdE21
November 17th 2019, 8:11pm
Tickeron @Tickeron
$ARNA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/G16itfurLc
November 17th 2019, 1:11pm
SharonAConklin @SharonAConklin
$UTHR $ARNA #AHA19 Ralinepag #PAH Phase 3 trials underway now. https://t.co/VBogZz366f
November 17th 2019, 11:11am
AHafizB @AHafizB
#stockpick pekan depan $ARNA . BUY 500, low vol (19-39), karena YTD cenderung sideways. Ada yang sama lihat cup-and… https://t.co/eb83NUz37x
November 17th 2019, 1:11am
Tickeron @Tickeron
$ARNA in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/4Zl5NlP4U1
November 16th 2019, 2:11pm
WatchlistN @WatchlistN
Arena Pharmaceuticals, Inc. $ARNA Director Sells $142,339.58 in Stock https://t.co/GYBC5lSNbN
November 16th 2019, 7:11am
bbnsnews @bbnsnews
Arena Pharmaceuticals, Inc. $ARNA Director Sells $142,339.58 in Stock https://t.co/v99BGOQy0b
November 16th 2019, 7:11am
Tickeron @Tickeron
$ARNA in Downtrend: RSI indicator enters oversold zone. View odds for this and other indicators:… https://t.co/Ic3RQBzVnR
November 15th 2019, 3:11pm
ZolmaxNews @ZolmaxNews
Randall E. Woods Sells 3,046 Shares of Arena Pharmaceuticals, Inc. $ARNA Stock https://t.co/ajfvLk2Yqs
November 15th 2019, 10:11am
Gambiste1 @Gambiste1
RT @SharonAConklin: $ARNA NEW Etrasimod Atopic Dermatitis (ADVISE) on https://t.co/GJdPGPgAki https://t.co/90NbkVUbDT 11 sites now recru…
November 15th 2019, 10:11am
SharonAConklin @SharonAConklin
$ARNA NEW Etrasimod Atopic Dermatitis (ADVISE) on https://t.co/GJdPGPgAki https://t.co/90NbkVUbDT 11 sites now recruiting.
November 15th 2019, 8:11am
BlueBioNow @BlueBioNow
$ARNA That's rough. . . -3.00 % change recently https://t.co/i2vzthav1u
November 14th 2019, 10:11pm
ConsumerFeed @ConsumerFeed
Arena Pharmaceuticals, Inc. $ARNA Director Randall E. Woods Sells 3,046 Shares https://t.co/5Je3BZ3lyh
November 14th 2019, 2:11pm
otcdynamics @otcdynamics
$ARNA Everest Medicines Achieved First Patient Dosing Milestone in Etrasimod Phase 3 Clinical Study in Ulcerative https://t.co/tQAVL4adFp
November 14th 2019, 9:11am
AmericanBanking @AmericanBanking
Wood & Company Reiterates Sell Rating for Arena Pharmaceuticals $ARNA https://t.co/wbCcve4PCK #stocks
November 14th 2019, 9:11am
SharonAConklin @SharonAConklin
$ARNA Arena and Everest Etrasimod Phase 3 dosing announced in Asia https://t.co/pzpfnLxdV8
November 14th 2019, 9:11am
dispatchtribune @dispatchtribune
Arena Pharmaceuticals, Inc. $ARNA Given Consensus Rating of “Hold” by Brokerages https://t.co/kWJW1z9ghV
November 14th 2019, 6:11am
AmericanBanking @AmericanBanking
Arena Pharmaceuticals, Inc. $ARNA Given Consensus Rating of “Hold” by Brokerages https://t.co/Mx1kcZUh8q #stocks
November 14th 2019, 6:11am
OlympiaReport @OlympiaReport
Arena Pharmaceuticals, Inc. $ARNA Receives Average Recommendation of “Hold” from Brokerages https://t.co/mkr8DDWQny
November 14th 2019, 6:11am
dailypoliticaln @dailypoliticaln
Arena Pharmaceuticals’ $ARNA Sell Rating Reaffirmed at Wood & Company https://t.co/KFXuu2C4Ro
November 14th 2019, 5:11am
ZolmaxNews @ZolmaxNews
Arena Pharmaceuticals’ $ARNA Sell Rating Reaffirmed at Wood & Company https://t.co/szIc6y5iZs
November 14th 2019, 5:11am
OlympiaReport @OlympiaReport
Arena Pharmaceuticals $ARNA Receives New Coverage from Analysts at Bank of America https://t.co/np5vv6Z6TT
November 14th 2019, 12:11am
dispatchtribune @dispatchtribune
Arena Pharmaceuticals $ARNA Receives New Coverage from Analysts at Bank of America https://t.co/ajD8LjTGmy
November 14th 2019, 12:11am
AmericanBanking @AmericanBanking
Bank of America Begins Coverage on Arena Pharmaceuticals $ARNA https://t.co/2VSiZbhjPT #stocks
November 14th 2019, 12:11am
AmericanBanking @AmericanBanking
Arena Pharmaceuticals, Inc. $ARNA Director Sells $142,339.58 in Stock https://t.co/Jv6kVGPo70 #stocks
November 13th 2019, 10:11pm
WeekHerald @WeekHerald
Arena Pharmaceuticals, Inc. $ARNA Director Sells $142,339.58 in Stock https://t.co/YC40RgrgGt
November 13th 2019, 9:11pm
ThisLincolnian @ThisLincolnian
Arena Pharmaceuticals, Inc. $ARNA Director Sells $142,339.58 in Stock https://t.co/kwTqJNwsn1
November 13th 2019, 9:11pm
MonitorAction @MonitorAction
$ARNA Randall Woods Dumps 3K Shares of ARENA PHARMACEUTICALS INC https://t.co/OaCq3oVlGc
November 13th 2019, 9:11pm
InsiderAlertsIA @InsiderAlertsIA
$ARNA: New Insider Filing on Director RANDALL E WOODS: https://t.co/k0Ehp5fSPD
November 13th 2019, 8:11pm
sleekoptions @sleekoptions
$ARNA stock was down -1.73 %. Turned Positive 0.24 % | (Red to green move) See other red to green mo ves using… https://t.co/k2V3bvSEKt
November 13th 2019, 8:11pm
StockTexts @StockTexts
$ARNA Arena Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/qeBfjMdSMe
November 13th 2019, 8:11pm
insiderbuyings @insiderbuyings
$ARNA new insider selling: 3046 shares. https://t.co/GqzV8Ue83A
November 13th 2019, 8:11pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.